BUNNAGE MARK E. (EVP, Chief Scientific Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2026ACC: 0000875320-26-000068
Officer· EVP, Chief Scientific Officer
Since Feb 2026
-2.28K
Net shares
Net seller
$1.11M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.28K
Price / share
$487.76
Trade value
$1.11M
% of position
17.7%
2/13/2026
12.91K→10.63K
Total
Net shares
−2.28K
Net value
-$1.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | F · Tax Withholding | −2.28K | $487.76 | $1.11M | 17.7% | 12.91K | 10.63K |
| Total | −2.28K | -$1.11M | ||||||
Derivative Transactions0
No derivative transactions reported